SEMMELWEIS UNIVERSITY, DEPARTMENT OF UROLOGY
TOPIC
Urology – Oncology (precision medicine in prostate/bladder cancer).
VISION
Precision medicine and individual molecular targeted therapy as a major breakthrough in oncology.
MISSION
Identify biomarkers that can guide optimal therapy sequencing in prostate and bladder cancers.
PROJECT TITLE 1
Therapeutic sensitivity to standard treatments in BRCA-positive metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
PROJECT TITLE 2
PARP inhibitors vs. platinum chemotherapy in BRCA-positive mCRPC: comparable efficacy – a systematic review and meta-analysis.